Biotechnology

  Infectious diseases have long posed a significant threat to India’s healthcare system. From tuberculosis to malaria and, more recently, the COVID-19 pandemic, outbreaks have tested the country’s public health infrastructure time and again. However, recent advancements in infectious disease diagnostics are transforming how India identifies, controls, and prevents these threats. With the rise of   biotechnology diagnostics in India , the country is now better equipped to tackle health challenges with precision, speed, and scale. The Shift Towards Advanced Diagnostics in India Traditionally, infectious diseases in India were diagnosed using manual, symptom-based, or time-consuming laboratory methods. These often delayed treatment and worsened patient outcomes. But the rise of  molecular diagnostics labs in India  has revolutionized this landscape. By leveraging tools such as  DNA sequencing services in India  and advanced genetic testing services, healthcare...

  Antimicrobial Resistance (AMR) is a growing global threat, and India is at the forefront of this crisis due to the high burden of infectious diseases and rampant misuse of antibiotics. The emergence of drug-resistant pathogens is rendering many traditional treatments ineffective, posing a serious challenge to the healthcare system. Amidst this alarming scenario,   biotechnology diagnostics in India   are proving to be powerful tools in identifying resistant pathogens, enabling targeted treatments, and curbing the spread of AMR. Understanding Antimicrobial Resistance in India India experiences one of the highest rates of bacterial infections globally, and the widespread use of antibiotics without prescriptions has accelerated resistance. AMR leads to longer hospital stays, higher medical costs, and increased mortality. To address this crisis, timely and accurate diagnosis of infections is critical. That’s where biotechnology comes in — offering precise, molecular-level i...